HDFC Bank Denies Defamatory Allegations, Plans Legal Action

An announcement from Hdfc Bank ( (HDB) ) is now available.

On June 12, 2025, HDFC Bank issued a statement addressing false and defamatory allegations made by the trustees of Lilavati Kirtilal Mehta Medical Trust against the bank and its MD & CEO. The bank categorically denied these claims, emphasizing its compliance with legal standards and ethical governance. HDFC Bank announced its intention to pursue legal action to protect its reputation and urged the public and media to critically assess the unfounded allegations, which it views as attempts to tarnish its image.

The most recent analyst rating on (HDB) stock is a Buy with a $74.00 price target. To see the full list of analyst forecasts on Hdfc Bank stock, see the HDB Stock Forecast page.

Spark’s Take on HDB Stock

According to Spark, TipRanks’ AI Analyst, HDB is a Outperform.

HDFC Bank’s overall score reflects strong financial health and positive technical momentum, balanced by fair valuation and mixed earnings call sentiment. Key strengths include robust income growth and stable credit metrics, while challenges arise from macroeconomic pressures and significant liabilities.

To see Spark’s full report on HDB stock, click here.

More about Hdfc Bank

HDFC Bank Limited is a prominent financial institution in India, operating in the banking industry. The bank offers a wide range of financial products and services, including retail banking, wholesale banking, and treasury operations. It is known for its strong governance and adherence to ethical standards, focusing on maintaining its reputation as one of India’s leading banks.

Average Trading Volume: 3,009,493

Technical Sentiment Signal: Buy

Current Market Cap: $176.3B

See more insights into HDB stock on TipRanks’ Stock Analysis page.